Factors Influencing Use of the Prostate-Specific Antigen Screening Test in Primary Care

William P. Moran, MD, MS;Stuart J. Cohen, EdD;John S. Preisser, PhD;James L. Wofford, MD, MS;Brent J. Shelton, MS;Maureen W. McClatchey, PhD;

Publication

Article

March 1, 2000

The American Journal of Managed Care

March 2000

Volume6

Issue 3

Factors Influencing Use of the Prostate-Specific Antigen Screening Test in Primary Care

Author(s):

William P. Moran, MD, MS,Stuart J. Cohen, EdD

Download PDF: Factors Influencing Use of the Prostate-Specific Antigen Screening Test in Primary Care

Articles in this issue

Cost and Quality under Managed Care: Irreconcilable Differences?

Factors Influencing Use of the Prostate-Specific Antigen Screening Test in Primary Care

Utilization and Effectiveness of a Weight-Based Heparin Nomogram at a Large Academic Medical Center

Opportunities and Challenges in Medicaid Managed Care: The Experience in Maryland

Healthcare Utilization among Hispanics: Findings from the 1994 Minority Health Survey

The Association between Pharmacy Closures and Prescription Drug Use: A Retrospective Analysis of Medicaid Prescription Claims in Iowa

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

September 5th 2025

State Restrictions on Prior Authorization

David H. Howard, PhD Alissa Durakovic

September 5th 2025

Managed Care Reflections: A Q&A With Dora Hughes, MD, MPH

Dora Hughes, MD, MPH Christina Mattina

September 5th 2025

Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending

Amber K. Sabbatini, MD, MPH David B. Muhlestein, PhD, JD Canada Parrish, PhD, MSPH Laura G. Burke, MD Kathleen Y. Li, MD, MSc Michelle P. Lin, MD, MSc

September 5th 2025

More Employers Offer Preventive Drug Lists Over Time

Anita K. Wagner, PharmD, DrPH, MPH Stephanie Argetsinger, MS, MPH Matt Lakoma, MPH Jenna Clemenzi, MPP Fang Zhang, PhD J. Frank Wharam, MD, MPH Dennis Ross-Degnan, ScD

September 5th 2025

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Maria Ukhanova, MD, PhD Joseph S. Wozny, MPH Chau N. Truong, PhD Lopita Ghosh, MBA Trudy M. Krause, DrPH

September 5th 2025

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

Mario Enrico Canonico, MD, PhD Judith Hsia, MD Shih-Ting Chiu, PhD Pu-Kai Tseng James O. Mudd, MD Joshua D. Remick, MD Bansi Patel, MS Ya-Hsiu Chuang, PhD Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC Marc P. Bonaca, MD, MPH

Related Content

September 5th 2025

State Restrictions on Prior Authorization

David H. Howard, PhD Alissa Durakovic

September 5th 2025

Managed Care Reflections: A Q&A With Dora Hughes, MD, MPH

Dora Hughes, MD, MPH Christina Mattina

September 5th 2025

Hospital Participation in Medicare ACOs: No Change in Admission Practices and Spending

Amber K. Sabbatini, MD, MPH David B. Muhlestein, PhD, JD Canada Parrish, PhD, MSPH Laura G. Burke, MD Kathleen Y. Li, MD, MSc Michelle P. Lin, MD, MSc

September 5th 2025

More Employers Offer Preventive Drug Lists Over Time

Anita K. Wagner, PharmD, DrPH, MPH Stephanie Argetsinger, MS, MPH Matt Lakoma, MPH Jenna Clemenzi, MPP Fang Zhang, PhD J. Frank Wharam, MD, MPH Dennis Ross-Degnan, ScD

September 5th 2025

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Maria Ukhanova, MD, PhD Joseph S. Wozny, MPH Chau N. Truong, PhD Lopita Ghosh, MBA Trudy M. Krause, DrPH

September 5th 2025

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

Factors Influencing Use of the Prostate-Specific Antigen Screening Test in Primary Care

Newsletter